Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
CanadaBis Capital, Inc. ( (TSE:CANB) ) has provided an announcement.
CanadaBis Capital Inc. reported strong financial results for the second quarter of 2025, with gross revenue reaching $9 million, marking a $2 million increase from the previous year. The company’s adjusted EBITDA stood at $434,158, reflecting effective cost-control measures and operational efficiency. CanadaBis continues to focus on growth and optimizing margins, implementing cost-saving initiatives and exploring new product offerings to strengthen its market position in a competitive cannabis industry.
More about CanadaBis Capital, Inc.
CanadaBis Capital Inc. is a vertically integrated Canadian cannabis company focused on large-scale growth in the global cannabis market, particularly in the concentrates category. Through its subsidiaries, including Stigma Grow, the company engages in cultivation, wholesale, extraction, and retail operations, utilizing a unique butane hydrocarbon extraction process to maintain competitive advantages.
YTD Price Performance: 58.33%
Average Trading Volume: 181,147
Technical Sentiment Signal: Sell
Current Market Cap: C$13.13M
Find detailed analytics on CANB stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue